| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adaptive Stress Responses During Tumor Metastasis and Dormancy
|
Senft, Daniela
|
|
2016
|
|
8 |
p. 429-442
|
artikel
|
| 2 |
Advanced Prostate Cancer: Treatment Advances and Future Directions
|
Swami, Umang
|
|
|
|
8 |
p. 702-715
|
artikel
|
| 3 |
Advisory Board and Contents
|
|
|
|
|
8 |
p. i-ii
|
artikel
|
| 4 |
Advisory Board and Contents
|
|
|
|
|
8 |
p. i-ii
|
artikel
|
| 5 |
Advisory Board and Contents
|
|
|
|
|
8 |
p. i-ii
|
artikel
|
| 6 |
Advisory Board and Contents
|
|
|
|
|
8 |
p. i-ii
|
artikel
|
| 7 |
Amyloid Evolvability and Cancer
|
Takamatsu, Yoshiki
|
|
|
|
8 |
p. 624-627
|
artikel
|
| 8 |
A new immuno-oncology target – SUMOylation
|
Chen, Yuan
|
|
|
|
8 |
p. 606-608
|
artikel
|
| 9 |
Autophagy Regulates Stress Responses, Metabolism, and Anticancer Immunity
|
White, Eileen
|
|
|
|
8 |
p. 778-789
|
artikel
|
| 10 |
Cancer Moonshot: Patents for Patients
|
Kovarik, Joseph E.
|
|
2018
|
|
8 |
p. 515-516
|
artikel
|
| 11 |
Cancer Nanomedicine: Lessons for Immuno-Oncology
|
Sengupta, Shiladitya
|
|
2017
|
|
8 |
p. 551-560
|
artikel
|
| 12 |
Carcinogens in Products: Inadequate Protections Raise Cancer Risks
|
Singla, Veena
|
|
|
|
8 |
p. 619-622
|
artikel
|
| 13 |
Challenges and opportunities for physician-scientists in advancing cancer research
|
Davidson, Nancy E.
|
|
|
|
8 |
p. 615-619
|
artikel
|
| 14 |
Challenges in glioblastoma research: focus on the tumor microenvironment
|
Bikfalvi, Andreas
|
|
|
|
8 |
p. 692
|
artikel
|
| 15 |
Deregulation of Retroelements as an Emerging Therapeutic Opportunity in Cancer
|
Ishak, Charles A.
|
|
2018
|
|
8 |
p. 583-597
|
artikel
|
| 16 |
Derisking Drug-Induced Carcinogenicity for Novel Therapeutics
|
Moggs, Jonathan G.
|
|
2016
|
|
8 |
p. 398-408
|
artikel
|
| 17 |
3D Spheroids Propel Tumor Characterization
|
Li, Shengli
|
|
|
|
8 |
p. 622-624
|
artikel
|
| 18 |
Editorial Board and Contents
|
|
|
2017
|
|
8 |
p. i
|
artikel
|
| 19 |
Editorial Board and Contents
|
|
|
2016
|
|
8 |
p. i
|
artikel
|
| 20 |
Editorial Board and Contents
|
|
|
2018
|
|
8 |
p. i
|
artikel
|
| 21 |
Editorial Board and Contents
|
|
|
2019
|
|
8 |
p. i
|
artikel
|
| 22 |
Emerging mechanisms of telomerase reactivation in cancer
|
Sharma, Shalu
|
|
|
|
8 |
p. 632-641
|
artikel
|
| 23 |
Emerging roles of nucleotide metabolism in cancer
|
Shi, Diana D.
|
|
|
|
8 |
p. 624-635
|
artikel
|
| 24 |
Enhancing the Efficacy of Glutamine Metabolism Inhibitors in Cancer Therapy
|
Yang, Wen-Hsuan
|
|
|
|
8 |
p. 790-804
|
artikel
|
| 25 |
Epigenetic Mechanisms Dictating Eradication of Cancer by Natural Killer Cells
|
Bugide, Suresh
|
|
2018
|
|
8 |
p. 553-566
|
artikel
|
| 26 |
Evolutionary Ecology of Organs: A Missing Link in Cancer Development?
|
Thomas, Frédéric
|
|
2016
|
|
8 |
p. 409-415
|
artikel
|
| 27 |
Exit Stage Left: A Tumor Cell’s Journey from Lymph Node to Beyond
|
Achen, Marc G.
|
|
2018
|
|
8 |
p. 519-522
|
artikel
|
| 28 |
Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment
|
Chiarella, Anna M.
|
|
|
|
8 |
p. 731-750
|
artikel
|
| 29 |
Genes that Mediate Metastasis across the Blood–Brain Barrier
|
Fares, Jawad
|
|
|
|
8 |
p. 660-676
|
artikel
|
| 30 |
Glycosylation and Integrin Regulation in Cancer
|
Marsico, Grazia
|
|
2018
|
|
8 |
p. 537-552
|
artikel
|
| 31 |
High-Fat Diet Impacts on Tumor Development in the Gut
|
van Driel, Milou S.
|
|
|
|
8 |
p. 664-665
|
artikel
|
| 32 |
IDH-Mutant Brain Tumors Hit the Achilles’ Heel of Macrophages with R-2-Hydroxyglutarate
|
van Dierendonck, Xanthe A.M.H.
|
|
|
|
8 |
p. 666-667
|
artikel
|
| 33 |
Immunometabolism: A ‘Hot’ Switch for ‘Cold’ Pediatric Solid Tumors
|
Xiao, Lin
|
|
|
|
8 |
p. 751-777
|
artikel
|
| 34 |
Improving CNS Delivery to Brain Metastases by Blood–Tumor Barrier Disruption
|
Sprowls, Samuel A.
|
|
2019
|
|
8 |
p. 495-505
|
artikel
|
| 35 |
Integrating Mathematical Modeling into the Roadmap for Personalized Adaptive Radiation Therapy
|
Enderling, Heiko
|
|
2019
|
|
8 |
p. 467-474
|
artikel
|
| 36 |
Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment
|
Sulli, Gabriele
|
|
2019
|
|
8 |
p. 475-494
|
artikel
|
| 37 |
In Vivo RNAi Screening for Pancreatic Cancer Drivers: PILOTing the WDR5–MYC Axis
|
Schneider, Günter
|
|
2016
|
|
8 |
p. 391-392
|
artikel
|
| 38 |
Janus Face of Drug-Induced Tetraploidy in Non-Hodgkin Lymphoma
|
Mahadevan, Daruka
|
|
|
|
8 |
p. 627-630
|
artikel
|
| 39 |
Lymph node metastasis fuels systemic disease
|
Ventre, Katherine S.
|
|
|
|
8 |
p. 623-625
|
artikel
|
| 40 |
Making a mouse out of a molehill: how precision modeling repurposes drugs for congenital giant nevi
|
Grafanaki, Katerina
|
|
|
|
8 |
p. 626-628
|
artikel
|
| 41 |
Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma
|
Han, Anna
|
|
|
|
8 |
p. 671-681
|
artikel
|
| 42 |
Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer
|
Rogers, Thomas
|
|
|
|
8 |
p. 700-713
|
artikel
|
| 43 |
Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy
|
Wang, Haiping
|
|
2017
|
|
8 |
p. 583-592
|
artikel
|
| 44 |
Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids
|
Pranzini, Erica
|
|
|
|
8 |
p. 682-699
|
artikel
|
| 45 |
Microfluidics meets 3D cancer cell migration
|
Mehta, Pranav
|
|
|
|
8 |
p. 683-697
|
artikel
|
| 46 |
Mitochondrial Stress Response and Cancer
|
O’Malley, Jordan
|
|
|
|
8 |
p. 688-701
|
artikel
|
| 47 |
Multifunctional role of thymidine phosphorylase in cancer
|
Warfield, Becka M.
|
|
|
|
8 |
p. 691
|
artikel
|
| 48 |
Multiregional Tumor Trees Are Not Phylogenies
|
Alves, João M.
|
|
2017
|
|
8 |
p. 546-550
|
artikel
|
| 49 |
NAD+ Deficits in Age-Related Diseases and Cancer
|
Garrido, Amanda
|
|
2017
|
|
8 |
p. 593-610
|
artikel
|
| 50 |
Nanotherapeutics for Antimetastatic Treatment
|
Yang, Fujun
|
|
|
|
8 |
p. 645-659
|
artikel
|
| 51 |
Natural killer cells: unlocking new treatments for bladder cancer
|
Ranti, Daniel
|
|
|
|
8 |
p. 698-710
|
artikel
|
| 52 |
Neuro-immune interactions and immuno-oncology
|
Khanmammadova, Narmina
|
|
|
|
8 |
p. 636-649
|
artikel
|
| 53 |
NF-κB in the New Era of Cancer Therapy
|
Eluard, Baptiste
|
|
|
|
8 |
p. 677-687
|
artikel
|
| 54 |
OPCML: A Promising Biomarker and Therapeutic Avenue
|
Simovic, Isidora
|
|
2019
|
|
8 |
p. 463-466
|
artikel
|
| 55 |
Repurposing Drugs in Oncology: Next Steps
|
Verbaanderd, Ciska
|
|
2017
|
|
8 |
p. 543-546
|
artikel
|
| 56 |
RHOA takes the RHOad less traveled to cancer
|
Schaefer, Antje
|
|
|
|
8 |
p. 655-669
|
artikel
|
| 57 |
RNA Splicing and Cancer
|
Wang, Eric
|
|
|
|
8 |
p. 631-644
|
artikel
|
| 58 |
Screening for Cancer in Persons Living with HIV Infection
|
Goedert, James J.
|
|
2016
|
|
8 |
p. 416-428
|
artikel
|
| 59 |
Seeking Convergence and Cure with New Myeloma Therapies
|
Choudhry, Priya
|
|
2018
|
|
8 |
p. 567-582
|
artikel
|
| 60 |
Self-reactive, innate-like T cells enhance cytotoxicity and immunosurveillance
|
Barton, Blaire E.
|
|
|
|
8 |
p. 629-631
|
artikel
|
| 61 |
Shadow mentoring: a cost–benefit review for reform
|
Davis-Reyes, Brionna
|
|
|
|
8 |
p. 620-622
|
artikel
|
| 62 |
Site matters in metastatic melanoma
|
Wilson, Haley P.
|
|
|
|
8 |
p. 603-605
|
artikel
|
| 63 |
Small Intestinal Cancer: Why the Rarity?
|
Lamprecht, Sergio
|
|
2016
|
|
8 |
p. 395-397
|
artikel
|
| 64 |
SOX4: Joining the Master Regulators of Epithelial-to-Mesenchymal Transition?
|
Lourenço, Ana Rita
|
|
2017
|
|
8 |
p. 571-582
|
artikel
|
| 65 |
Spatial determinants of CD8+ T cell differentiation in cancer
|
Tooley, Katherine A.
|
|
|
|
8 |
p. 642-654
|
artikel
|
| 66 |
STAG Mutations in Cancer
|
Romero-Pérez, Laura
|
|
2019
|
|
8 |
p. 506-520
|
artikel
|
| 67 |
Subscription and copyright page
|
|
|
|
|
8 |
p. e1
|
artikel
|
| 68 |
Subscription & Copyright Page
|
|
|
2019
|
|
8 |
p. e1
|
artikel
|
| 69 |
Subscription & copyright page
|
|
|
|
|
8 |
p. e1
|
artikel
|
| 70 |
Subscription & copyright page
|
|
|
|
|
8 |
p. e1
|
artikel
|
| 71 |
Subscription & copyright page
|
|
|
|
|
8 |
p. e1
|
artikel
|
| 72 |
Targeting BCL-2-like Proteins to Kill Cancer Cells
|
Cory, Suzanne
|
|
2016
|
|
8 |
p. 443-460
|
artikel
|
| 73 |
Targeting Metabolic Bottlenecks in Lung Cancer
|
Sayin, Volkan I.
|
|
2019
|
|
8 |
p. 457-459
|
artikel
|
| 74 |
Targeting phagocytosis to enhance antitumor immunity
|
Huntoon, Kristin
|
|
|
|
8 |
p. 650-665
|
artikel
|
| 75 |
Targeting Serine in Cancer: Is Two Better Than One?
|
Buqué, Aitziber
|
|
|
|
8 |
p. 668-670
|
artikel
|
| 76 |
γδ T Cells: Unexpected Regulators of Cancer Development and Progression
|
Fleming, Christopher
|
|
2017
|
|
8 |
p. 561-570
|
artikel
|
| 77 |
The conundrum of Helicobacter pylori-associated apoptosis in gastric cancer
|
Lim, Michelle C.C.
|
|
|
|
8 |
p. 679-690
|
artikel
|
| 78 |
The Making of a PreCancer Atlas: Promises, Challenges, and Opportunities
|
Srivastava, Sudhir
|
|
2018
|
|
8 |
p. 523-536
|
artikel
|
| 79 |
The peritumor microenvironment: physics and immunity
|
Zhang, Sue
|
|
|
|
8 |
p. 609-623
|
artikel
|
| 80 |
The PreCancer Atlas (PCA)
|
Srivastava, Sudhir
|
|
2018
|
|
8 |
p. 513-514
|
artikel
|
| 81 |
Therapeutic Repurposing of Biguanides in Cancer
|
Zhao, Hongyun
|
|
|
|
8 |
p. 714-730
|
artikel
|
| 82 |
The Tumor Microenvironment Takes Center Stage in Ovarian Cancer Metastasis
|
Curtis, Marion
|
|
2018
|
|
8 |
p. 517-519
|
artikel
|
| 83 |
Thymic expression of immune checkpoint molecules and their implication for response to immunotherapies
|
Caruso, Breanna
|
|
|
|
8 |
p. 666-678
|
artikel
|
| 84 |
Utilizing chemokines in cancer immunotherapy
|
Märkl, Florian
|
|
|
|
8 |
p. 670-682
|
artikel
|
| 85 |
Vascular Detransformation for Cancer Therapy
|
Fan, Yi
|
|
2019
|
|
8 |
p. 460-463
|
artikel
|
| 86 |
Watson for Genomics: Moving Personalized Medicine Forward
|
Rhrissorrakrai, Kahn
|
|
2016
|
|
8 |
p. 392-395
|
artikel
|
| 87 |
Zebrafish as a New Model to Study the Crosstalk between Tumor and Host Metabolism
|
Montal, Emily
|
|
|
|
8 |
p. 661-663
|
artikel
|
Tijdschrift beschrijving